Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1,800,000 Profiles
- More than 3,500 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Jacquie Astemborski
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.8 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Activities & Behaviors
Disorders
Concepts & Ideas
Phenomena
Living Beings
Procedures
Chemicals & Drugs
Geographic Areas
Physiology
Sign-in to see full Profile
Network (preview)
55
Vlahov, David
33
Thomas, David
26
Nelson, Kenrad
13
Mehta, Shruti
12
Galai, Noya
11
Thio, Chloe
11
Strathdee, Steffanie
11
Graham, Neil
10
Kirk, Gregory
10
Margolick, Joseph
8
MUNOZ, ALVARO
8
O'Brien, Stephen
7
Lyles, CM
7
Carrington, Mary
7
Goedert, James
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Jacquie Astemborski (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2010: Mehta Shruti H; Kirk Gregory D; Astemborski Jacquie; Galai Noya; Celentano David D
Temporal trends in highly active antiretroviral therapy initiation among injection drug users in Baltimore, Maryland, 1996-2008.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2010;50(12):1664-71.
-
2009: Kirk Gregory D; Astemborski Jacquie; Mehta Shruti H; Spoler Chuck; Fisher Cedric; Allen Danisha; Higgins Yvonne; Moore Richard D; Afdhal Nezem; Torbenson Michael; Sulkowski Mark; Thomas David L
Assessment of liver fibrosis by transient elastography in persons with hepatitis C virus infection or HIV-hepatitis C virus coinfection.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009;48(7):963-72.
-
2009: Kavasery Ravi; Galai Noya; Astemborski Jacquie; Lucas Gregory M; Celentano David D; Kirk Gregory D; Mehta Shruti H
Nonstructured treatment interruptions among injection drug users in Baltimore, MD.
Journal of acquired immune deficiency syndromes (1999) 2009;50(4):360-6.
-
2008: Rutebemberwa Alleluiah; Ray Stuart C; Astemborski Jacquie; Levine Jordana; Liu Lin; Dowd Kimberly A; Clute Shalyn; Wang Changyu; Korman Alan; Sette Alessandro; Sidney John; Pardoll Drew M; Cox Andrea L
High-programmed death-1 levels on hepatitis C virus-specific T cells during acute infection are associated with viral persistence and require preservation of cognate antigen during chronic infection.
Journal of immunology (Baltimore, Md. : 1950) 2008;181(12):8215-25.
-
2008: Golub Jonathan E; Astemborski Jacquie; Ahmed Mohammed; Cronin Wendy; Mehta Shruti H; Kirk Gregory D; Vlahov David; Chaisson Richard E
Long-term effectiveness of diagnosing and treating latent tuberculosis infection in a cohort of HIV-infected and at-risk injection drug users.
Journal of acquired immune deficiency syndromes (1999) 2008;49(5):532-7.
-
2008: Thio Chloe L; Astemborski Jacquie; Thomas Rasmi; Mosbruger Timothy; Witt Mallory D; Goedert James J; Hoots Keith; Winkler Cherie; Thomas David L; Carrington Mary
Interaction between RANTES promoter variant and CCR5Delta32 favors recovery from hepatitis B.
Journal of immunology (Baltimore, Md. : 1950) 2008;181(11):7944-7.
-
2008: Blankson Joel N; Klinzman Donna; Astemborski Jacquie; Thomas David L; Kirk Gregory D; Stapleton Jack T
Low frequency of GB virus C viremia in a cohort of HIV-1-infected elite suppressors.
AIDS (London, England) 2008;22(17):2398-400.
-
2008: Balagopal Ashwin; Philp Frances H; Astemborski Jacquie; Block Timothy M; Mehta Anand; Long Ronald; Kirk Gregory D; Mehta Shruti H; Cox Andrea L; Thomas David L; Ray Stuart C
Human immunodeficiency virus-related microbial translocation and progression of hepatitis C.
Gastroenterology 2008;135(1):226-33.
-
2008: Mehta Shruti H; Genberg Becky L; Astemborski Jacquie; Kavasery Ravi; Kirk Gregory D; Vlahov David; Strathdee Steffanie A; Thomas David L
Limited uptake of hepatitis C treatment among injection drug users.
Journal of community health 2008;33(3):126-33.
-
2008: Pandey Janardan P; Luo Yuqun; Elston Robert C; Wu Yuping; Philp Frances Hite; Astemborski Jacquie; Thomas David L; Netski Dale M
Immunoglobulin allotypes influence IgG antibody responses to hepatitis C virus envelope proteins E1 and E2.
Human immunology 2008;69(3):158-64.
-
2007: Wang Xiao-Hong; Netski Dale M; Astemborski Jacquie; Mehta Shruti H; Torbenson Michael S; Thomas David L; Ray Stuart C
Progression of fibrosis during chronic hepatitis C is associated with rapid virus evolution.
Journal of virology 2007;81(12):6513-22.
-
2007: Mehta S H; Lucas G; Astemborski J; Kirk G D; Vlahov D; Galai N
Early immunologic and virologic responses to highly active antiretroviral therapy and subsequent disease progression among HIV-infected injection drug users.
AIDS care 2007;19(5):637-45.
-
2007: Netski Dale M; Mosbruger Tim; Astemborski Jacquie; Mehta Shruti H; Thomas David L; Cox Andrea L
CD4+ T cell-dependent reduction in hepatitis C virus-specific humoral immune responses after HIV infection.
The Journal of infectious diseases 2007;195(6):857-63.
-
2007: Thio Chloe L; Astemborski Jacquie; Bashirova Arman; Mosbruger Timothy; Greer Spencer; Witt Mallory D; Goedert James J; Hilgartner Margaret; Majeske Audrey; O'Brien Stephen J; Thomas David L; Carrington Mary
Genetic protection against hepatitis B virus conferred by CCR5Delta32: Evidence that CCR5 contributes to viral persistence.
Journal of virology 2007;81(2):441-5.
-
2006: Mehta Shruti H; Galai Noya; Astemborski Jacquie; Celentano David D; Strathdee Steffanie A; Vlahov David; Nelson Kenrad E
HIV incidence among injection drug users in Baltimore, Maryland (1988-2004).
Journal of acquired immune deficiency syndromes (1999) 2006;43(3):368-72.
-
2006: Wilson Lucy E; Torbenson Michael; Astemborski Jacquie; Faruki Hawazin; Spoler Charles; Rai Rudra; Mehta Shruti; Kirk Gregory D; Nelson Kenrad; Afdhal Nezam; Thomas David L
Progression of liver fibrosis among injection drug users with chronic hepatitis C.
Hepatology (Baltimore, Md.) 2006;43(4):788-95.
-
2006: Mehta Shruti H; Astemborski Jacquie; Sterling Timothy R; Thomas David L; Vlahov David
Serum albumin as a prognostic indicator for HIV disease progression.
AIDS research and human retroviruses 2006;22(1):14-21.
-
2005: Thio Chloe L; Mosbruger Timothy; Astemborski Jacquie; Greer Spencer; Kirk Gregory D; O'Brien Stephen J; Thomas David L
Mannose binding lectin genotypes influence recovery from hepatitis B virus infection.
Journal of virology 2005;79(14):9192-6.
-
2005: Kelleher Thomas B; Mehta Shruti H; Bhaskar Ramakrishnan; Sulkowski Mark; Astemborski Jacquie; Thomas David L; Moore Richard E; Afdhal Nezam H
Prediction of hepatic fibrosis in HIV/HCV co-infected patients using serum fibrosis markers: the SHASTA index.
Journal of hepatology 2005;43(1):78-84.
-
2005: Sterling Timothy R; Pisell-Noland Tracy; Perez John L; Astemborski Jacquie; McGriff Joelle R; Nutting Lisa; Hoover Donald R; Vlahov David; Bollinger Robert C
Sex-based differences in T lymphocyte responses in HIV-1-seropositive individuals.
The Journal of infectious diseases 2005;191(6):881-5.
-
2004: Dezzutti Charlene S; Astemborski Jacquie; Thomas David L; Marshall James H; Cabrera Thania; Purdy Michael; Vlahov David; Garfein Richard S
Prevalence of cryoglobulinemia in hepatitis C virus (HCV) positive patients with and without human immunodeficiency virus (HIV) coinfection.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2004;31(3):210-4.
-
2004: Thio Chloe L; Mosbruger Timothy L; Kaslow Richard A; Karp Christopher L; Strathdee Steffanie A; Vlahov David; O'Brien Stephen J; Astemborski Jacquie; Thomas David L
Cytotoxic T-lymphocyte antigen 4 gene and recovery from hepatitis B virus infection.
Journal of virology 2004;78(20):11258-62.
-
2004: Khakoo Salim I; Thio Chloe L; Martin Maureen P; Brooks Collin R; Gao Xiaojiang; Astemborski Jacquie; Cheng Jie; Goedert James J; Vlahov David; Hilgartner Margaret; Cox Steven; Little Ann-Margeret; Alexander Graeme J; Cramp Matthew E; O'Brien Stephen J; Rosenberg William M C; Thomas David L; Carrington Mary
HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection.
Science (New York, N.Y.) 2004;305(5685):872-4.
-
2004: Thio C L; Goedert J J; Mosbruger T; Vlahov D; Strathdee S A; O'Brien S J; Astemborski J; Thomas D L
An analysis of tumor necrosis factor alpha gene polymorphisms and haplotypes with natural clearance of hepatitis C virus infection.
Genes and immunity 2004;5(4):294-300.
-
2004: Pandey Janardan P; Astemborski Jacquie; Thomas David L
Epistatic effects of immunoglobulin GM and KM allotypes on outcome of infection with hepatitis C virus.
Journal of virology 2004;78(9):4561-5.
-
2004: Torbenson Michael; Kannangai Rajesh; Astemborski Jacquie; Strathdee Steffanie A; Vlahov David; Thomas David L
High prevalence of occult hepatitis B in Baltimore injection drug users.
Hepatology (Baltimore, Md.) 2004;39(1):51-7.
-
2003: Thio Chloe L; Thomas David L; Karacki Peter; Gao Xiaojiang; Marti Darlene; Kaslow Richard A; Goedert James J; Hilgartner Margaret; Strathdee Steffanie A; Duggal Priya; O'Brien Stephen J; Astemborski Jacquie; Carrington Mary
Comprehensive analysis of class I and class II HLA antigens and chronic hepatitis B virus infection.
Journal of virology 2003;77(22):12083-7.
-
2003: Golub Elizabeth T; Astemborski Jacquie A; Hoover Donald R; Anthony James C; Vlahov David; Strathdee Steffanie A
Psychological distress and progression to AIDS in a cohort of injection drug users.
Journal of acquired immune deficiency syndromes (1999) 2003;32(4):429-34.
-
2002: Sterling Timothy R; Hoover Donald R; Astemborski Jacquie; Vlahov David; Bartlett John G; Schupbach Jorg
Heat-denatured human immunodeficiency virus type 1 protein 24 antigen: prognostic value in adults with early-stage disease.
The Journal of infectious diseases 2002;186(8):1181-5.
-
2002: Wilson Lucy E; Thomas David L; Astemborski Jacqueline; Freedman Terri L; Vlahov David
Prospective study of infective endocarditis among injection drug users.
The Journal of infectious diseases 2002;185(12):1761-6.
-
2002: Rai Rudra; Wilson Lucy E; Astemborski Jacquie; Anania Frank; Torbenson Michael; Spoler Charles; Vlahov David; Strathdee Steffanie A; Boitnott John; Nelson Kenrad E; Thomas David L
Severity and correlates of liver disease in hepatitis C virus-infected injection drug users.
Hepatology (Baltimore, Md.) 2002;35(5):1247-55.
-
2002: Thio Chloe L; Gao Xiaojiang; Goedert James J; Vlahov David; Nelson Kenrad E; Hilgartner Margaret W; O'Brien Stephen J; Karacki Peter; Astemborski Jacquie; Carrington Mary; Thomas David L
HLA-Cw*04 and hepatitis C virus persistence.
Journal of virology 2002;76(10):4792-7.
-
2001: Wilson L E; Umemura T; Astemborski J; Ray S C; Alter H J; Strathdee S A; Vlahov D; Thomas D L
Dynamics of SEN virus infection among injection drug users.
The Journal of infectious diseases 2001;184(10):1315-9.
-
2001: Sadaphal P; Astemborski J; Graham N M; Sheely L; Bonds M; Madison A; Vlahov D; Thomas D L; Sterling T R
Isoniazid preventive therapy, hepatitis C virus infection, and hepatotoxicity among injection drug users infected with Mycobacterium tuberculosis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2001;33(10):1687-91.
-
2001: Ahdieh L; Klein R S; Burk R; Cu-Uvin S; Schuman P; Duerr A; Safaeian M; Astemborski J; Daniel R; Shah K
Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women.
The Journal of infectious diseases 2001;184(6):682-90.
-
2001: Thio C L; Thomas D L; Goedert J J; Vlahov D; Nelson K E; Hilgartner M W; O'Brien S J; Karacki P; Marti D; Astemborski J; Carrington M
Racial differences in HLA class II associations with hepatitis C virus outcomes.
The Journal of infectious diseases 2001;184(1):16-21.
-
2001: Thomas D L; Rich J D; Schuman P; Smith D K; Astemborski J A; Nolt K R; Klein R S
Multicenter evaluation of hepatitis C RNA levels among female injection drug users.
The Journal of infectious diseases 2001;183(6):973-6.
-
2001: Sterling T R; Vlahov D; Astemborski J; Hoover D R; Margolick J B; Quinn T C
Initial plasma HIV-1 RNA levels and progression to AIDS in women and men.
The New England journal of medicine 2001;344(10):720-5.
-
2000: Thomas D L; Astemborski J; Rai R M; Anania F A; Schaeffer M; Galai N; Nolt K; Nelson K E; Strathdee S A; Johnson L; Laeyendecker O; Boitnott J; Wilson L E; Vlahov D
The natural history of hepatitis C virus infection: host, viral, and environmental factors.
JAMA : the journal of the American Medical Association 2000;284(4):450-6.
-
2000: Thomas D L; Astemborski J; Vlahov D; Strathdee S A; Ray S C; Nelson K E; Galai N; Nolt K R; Laeyendecker O; Todd J A
Determinants of the quantity of hepatitis C virus RNA.
The Journal of infectious diseases 2000;181(3):844-51.
-
2000: Thio C L; Nolt K R; Astemborski J; Vlahov D; Nelson K E; Thomas D L
Screening for hepatitis C virus in human immunodeficiency virus-infected individuals.
Journal of clinical microbiology 2000;38(2):575-7.
-
1999: Sterling T R; Lyles C M; Vlahov D; Astemborski J; Margolick J B; Quinn T C
Sex differences in longitudinal human immunodeficiency virus type 1 RNA levels among seroconverters.
The Journal of infectious diseases 1999;180(3):666-72.
-
1999: Kimura M; Converse P J; Astemborski J; Rothel J S; Vlahov D; Comstock G W; Graham N M; Chaisson R E; Bishai W R
Comparison between a whole blood interferon-gamma release assay and tuberculin skin testing for the detection of tuberculosis infection among patients at risk for tuberculosis exposure.
The Journal of infectious diseases 1999;179(5):1297-300.
-
1999: Rompalo A M; Astemborski J; Schoenbaum E; Schuman P; Carpenter C; Holmberg S D; Warren D L; Farzadegan H; Vlahov D; Smith D K
Comparison of clinical manifestations of HIV infection among women by risk group, CD4+ cell count, and HIV-1 plasma viral load. HER Study Group. HIV Epidemiology Research.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1999;20(5):448-54.
-
1999: Thio C L; Carrington M; Marti D; O'Brien S J; Vlahov D; Nelson K E; Astemborski J; Thomas D L
Class II HLA alleles and hepatitis B virus persistence in African Americans.
The Journal of infectious diseases 1999;179(4):1004-6.
-
1999: Pezzotti P; Galai N; Vlahov D; Rezza G; Lyles C M; Astemborski J
Direct comparison of time to AIDS and infectious disease death between HIV seroconverter injection drug users in Italy and the United States: results from the ALIVE and ISS studies. AIDS Link to Intravenous Experiences. Italian Seroconversion Study.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1999;20(3):275-82.
-
1999: Lyles C M; Graham N M; Astemborski J; Vlahov D; Margolick J B; Saah A J; Farzadegan H
Cell-associated infectious HIV-1 viral load as a predictor of clinical progression and survival among HIV-1 infected injection drug users and homosexual men.
European journal of epidemiology 1999;15(2):99-108.
-
1998: Lyles C M; Vlahov D; Farzadegan H; Astemborski J; Margolick J B; Masters B A; Schroeder J; Quinn T C
Comparison of two measures of human immunodeficiency virus (HIV) type 1 load in HIV risk groups.
Journal of clinical microbiology 1998;36(12):3647-52.
-
1998: Bishai W R; Graham N M; Harrington S; Pope D S; Hooper N; Astemborski J; Sheely L; Vlahov D; Glass G E; Chaisson R E
Molecular and geographic patterns of tuberculosis transmission after 15 years of directly observed therapy.
JAMA : the journal of the American Medical Association 1998;280(19):1679-84.
-
1998: Farzadegan H; Hoover D R; Astemborski J; Lyles C M; Margolick J B; Markham R B; Quinn T C; Vlahov D
Sex differences in HIV-1 viral load and progression to AIDS.
Lancet 1998;352(9139):1510-4.
-
1998: Sterling T R; Moore R D; Graham N M; Astemborski J; Vlahov D; Chaisson R E
Mycobacterium tuberculosis infection and disease are not associated with protection against subsequent disseminated M. avium complex disease.
AIDS (London, England) 1998;12(12):1451-7.
-
1998: Thomas D L; Vlahov D; Alter H J; Hunt J C; Marshall R; Astemborski J; Nelson K E
Association of antibody to GB virus C (hepatitis G virus) with viral clearance and protection from reinfection.
The Journal of infectious diseases 1998;177(3):539-42.
-
1997: Thomas D L; Nakatsuji Y; Shih J W; Alter H J; Nelson K E; Astemborski J A; Lyles C M; Vlahov D
Persistence and clinical significance of hepatitis G virus infections in injecting drug users.
The Journal of infectious diseases 1997;176(3):586-92.
-
1997: Lyles C M; Margolick J B; Astemborski J; Graham N M; Anthony J C; Hoover D R; Vlahov D
The influence of drug use patterns on the rate of CD4+ lymphocyte decline among HIV-1-infected injecting drug users.
AIDS (London, England) 1997;11(10):1255-62.
-
1997: Converse P J; Jones S L; Astemborski J; Vlahov D; Graham N M
Comparison of a tuberculin interferon-gamma assay with the tuberculin skin test in high-risk adults: effect of human immunodeficiency virus infection.
The Journal of infectious diseases 1997;176(1):144-50.
-
1996: Manoff S B; Farzadegan H; Muñoz A; Astemborski J A; Vlahov D; Rizzo R T; Solomon L; Graham N M
The effect of latent Mycobacterium tuberculosis infection on human immunodeficiency virus (HIV) disease progression and HIV RNA load among injecting drug users.
The Journal of infectious diseases 1996;174(2):299-308.
-
1996: Galai N; Margolick J B; Astemborski J; Vlahov D
Existence and failure of T-cell homeostasis prior to AIDS onset in HIV-infected injection drug users.
Clinical immunology and immunopathology 1996;79(2):134-41.
-
1996: Graham N M; Galai N; Nelson K E; Astemborski J; Bonds M; Rizzo R T; Sheeley L; Vlahov D
Effect of isoniazid chemoprophylaxis on HIV-related mycobacterial disease.
Archives of internal medicine 1996;156(8):889-94.
-
1994: Caiaffa W T; Vlahov D; Graham N M; Astemborski J; Solomon L; Nelson K E; Muñoz A
Drug smoking, Pneumocystis carinii pneumonia, and immunosuppression increase risk of bacterial pneumonia in human immunodeficiency virus-seropositive injection drug users.
American journal of respiratory and critical care medicine 1994;150(6 Pt 1):1493-8.
-
1994: Vlahov D; Astemborski J; Solomon L; Nelson K E
Field effectiveness of needle disinfection among injecting drug users.
Journal of acquired immune deficiency syndromes 1994;7(7):760-6.
-
1994: Vlahov D; Muñoz A; Solomon L; Astemborski J; Lindsay A; Anderson J; Galai N; Nelson K E
Comparison of clinical manifestations of HIV infection between male and female injecting drug users.
AIDS (London, England) 1994;8(6):819-23.
-
1994: Margolick J B; Muñoz A; Vlahov D; Astemborski J; Solomon L; He X Y; Nelson K E; Saah A J
Direct comparison of the relationship between clinical outcome and change in CD4+ lymphocytes in human immunodeficiency virus-positive homosexual men and injecting drug users.
Archives of internal medicine 1994;154(8):869-75.
-
1994: Astemborski J; Vlahov D; Warren D; Solomon L; Nelson K E
The trading of sex for drugs or money and HIV seropositivity among female intravenous drug users.
American journal of public health 1994;84(3):382-7.
-
1994: Vlahov D; Astemborski J; Solomon L; Galai N; Basarab L; Nelson K E
Interest in HIV vaccines among injection drug users in Baltimore, Maryland.
AIDS research and human retroviruses 1994;10 Suppl 2():S265-8.
-
1994: Nelson K E; Vlahov D; Galai N; Astemborski J; Solomon L
Preparations for AIDS vaccine trials. Incident human immunodeficiency virus (HIV) infections in a cohort of injection drug users in Baltimore, Maryland.
AIDS research and human retroviruses 1994;10 Suppl 2():S201-5.
-
1993: Farzadegan H; Vlahov D; Solomon L; Muñoz A; Astemborski J; Taylor E; Burnley A; Nelson K E
Detection of human immunodeficiency virus type 1 infection by polymerase chain reaction in a cohort of seronegative intravenous drug users.
The Journal of infectious diseases 1993;168(2):327-31.
-
1993: Solomon L; Astemborski J; Warren D; Muñoz A; Cohn S; Vlahov D; Nelson K E
Differences in risk factors for human immunodeficiency virus type 1 seroconversion among male and female intravenous drug users.
American journal of epidemiology 1993;137(8):892-8.
-
1992: Vlahov D; Sullivan M; Astemborski J; Nelson K E
Bacterial infections and skin cleaning prior to injection among intravenous drug users.
Public health reports (Washington, D.C. : 1974) 1992;107(5):595-8.
-
1992: Margolick J B; Muñoz A; Vlahov D; Solomon L; Astemborski J; Cohn S; Nelson K E
Changes in T-lymphocyte subsets in intravenous drug users with HIV-1 infection.
JAMA : the journal of the American Medical Association 1992;267(12):1631-6.
-
1992: Graham N M; Nelson K E; Solomon L; Bonds M; Rizzo R T; Scavotto J; Astemborski J; Vlahov D
Prevalence of tuberculin positivity and skin test anergy in HIV-1-seropositive and -seronegative intravenous drug users.
JAMA : the journal of the American Medical Association 1992;267(3):369-73.
-
1992: Muñoz A; Vlahov D; Solomon L; Margolick J B; Bareta J C; Cohn S; Astemborski J; Nelson K E
Prognostic indicators for development of AIDS among intravenous drug users.
Journal of acquired immune deficiency syndromes 1992;5(7):694-700.
-
1991: Anthony J C; Vlahov D; Nelson K E; Cohn S; Astemborski J; Solomon L
New evidence on intravenous cocaine use and the risk of infection with human immunodeficiency virus type 1.
American journal of epidemiology 1991;134(10):1175-89.
-
1991: Solomon L; Frank R; Vlahov D; Astemborski J
Utilization of health services in a cohort of intravenous drug users with known HIV-1 serostatus.
American journal of public health 1991;81(10):1285-90.
Sign-in to see more
